International Clinical Trial: Adaptive Phase I clinical study to evaluate the safety, tolerability and performance of VXM-305-00-P, an intradermal high-density microarray patch (HD-MAP) delivery system, in healthy children and adult parent/guardians

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001115325) titled 'Adaptive Phase I clinical study to evaluate the safety, tolerability and performance of VXM-305-00-P, an intradermal high-density microarray patch (HD-MAP) delivery system, in healthy children and adult parent/guardians' on Sept. 8.

Study Type: Interventional

Study Design: Purpose: Prevention Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Safety

Primary Sponsor: Vaxxas Pty Ltd

Condition: Vaccination Vaccination Public Health - Other public health

Intervention: Vaxxas Pty Ltd is developing a novel needle-free high-density microarray pa...